281 related articles for article (PubMed ID: 27982511)
1. Biochemical Changes in the Niche Following Tumor Cell Invasion.
Decker AM; Cackowski FC; Jung Y; Taichman RS
J Cell Biochem; 2017 Aug; 118(8):1956-1964. PubMed ID: 27982511
[TBL] [Abstract][Full Text] [Related]
2. The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer.
Shiozawa Y; Berry JE; Eber MR; Jung Y; Yumoto K; Cackowski FC; Yoon HJ; Parsana P; Mehra R; Wang J; McGee S; Lee E; Nagrath S; Pienta KJ; Taichman RS
Oncotarget; 2016 Jul; 7(27):41217-41232. PubMed ID: 27172799
[TBL] [Abstract][Full Text] [Related]
3. GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.
Shiozawa Y; Pedersen EA; Patel LR; Ziegler AM; Havens AM; Jung Y; Wang J; Zalucha S; Loberg RD; Pienta KJ; Taichman RS
Neoplasia; 2010 Feb; 12(2):116-27. PubMed ID: 20126470
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer and parasitism of the bone hematopoietic stem cell niche.
Yu C; Shiozawa Y; Taichman RS; McCauley LK; Pienta K; Keller E
Crit Rev Eukaryot Gene Expr; 2012; 22(2):131-48. PubMed ID: 22856431
[TBL] [Abstract][Full Text] [Related]
5. Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow.
Shiozawa Y; Pedersen EA; Havens AM; Jung Y; Mishra A; Joseph J; Kim JK; Patel LR; Ying C; Ziegler AM; Pienta MJ; Song J; Wang J; Loberg RD; Krebsbach PH; Pienta KJ; Taichman RS
J Clin Invest; 2011 Apr; 121(4):1298-312. PubMed ID: 21436587
[TBL] [Abstract][Full Text] [Related]
6. Interferon-Mediated Tumor Resistance to Oncolytic Virotherapy.
Ebrahimi S; Ghorbani E; Khazaei M; Avan A; Ryzhikov M; Azadmanesh K; Hassanian SM
J Cell Biochem; 2017 Aug; 118(8):1994-1999. PubMed ID: 28135008
[TBL] [Abstract][Full Text] [Related]
7. The prostate cancer bone marrow niche: more than just 'fertile soil'.
Pedersen EA; Shiozawa Y; Pienta KJ; Taichman RS
Asian J Androl; 2012 May; 14(3):423-7. PubMed ID: 22367179
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors.
Shiozawa Y; Pienta KJ; Taichman RS
Clin Cancer Res; 2011 Sep; 17(17):5553-8. PubMed ID: 21676926
[TBL] [Abstract][Full Text] [Related]
9. Niche Extracellular Matrix Components and Their Influence on HSC.
Domingues MJ; Cao H; Heazlewood SY; Cao B; Nilsson SK
J Cell Biochem; 2017 Aug; 118(8):1984-1993. PubMed ID: 28112429
[TBL] [Abstract][Full Text] [Related]
10. Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.
Jung Y; Cackowski FC; Yumoto K; Decker AM; Wang Y; Hotchkin M; Lee E; Buttitta L; Taichman RS
Neoplasia; 2021 Jan; 23(1):102-111. PubMed ID: 33296752
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.
Jung Y; Shiozawa Y; Wang J; McGregor N; Dai J; Park SI; Berry JE; Havens AM; Joseph J; Kim JK; Patel L; Carmeliet P; Daignault S; Keller ET; McCauley LK; Pienta KJ; Taichman RS
Neoplasia; 2012 May; 14(5):429-39. PubMed ID: 22745589
[TBL] [Abstract][Full Text] [Related]
12. Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.
Decker AM; Jung Y; Cackowski FC; Yumoto K; Wang J; Taichman RS
Mol Cancer Res; 2017 Dec; 15(12):1644-1655. PubMed ID: 28814453
[TBL] [Abstract][Full Text] [Related]
13. Exploiting bone niches: progression of disseminated tumor cells to metastasis.
Muscarella AM; Aguirre S; Hao X; Waldvogel SM; Zhang XH
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720051
[TBL] [Abstract][Full Text] [Related]
14. Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow.
Jung Y; Decker AM; Wang J; Lee E; Kana LA; Yumoto K; Cackowski FC; Rhee J; Carmeliet P; Buttitta L; Morgan TM; Taichman RS
Oncotarget; 2016 May; 7(18):25698-711. PubMed ID: 27028863
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow neoplastic niche in leukemia.
Azizidoost S; Babashah S; Rahim F; Shahjahani M; Saki N
Hematology; 2014 Jun; 19(4):232-8. PubMed ID: 23905984
[TBL] [Abstract][Full Text] [Related]
16. TBK1 regulates prostate cancer dormancy through mTOR inhibition.
Kim JK; Jung Y; Wang J; Joseph J; Mishra A; Hill EE; Krebsbach PH; Pienta KJ; Shiozawa Y; Taichman RS
Neoplasia; 2013 Sep; 15(9):1064-74. PubMed ID: 24027431
[TBL] [Abstract][Full Text] [Related]
17. The molecular signature of the stroma response in prostate cancer-induced osteoblastic bone metastasis highlights expansion of hematopoietic and prostate epithelial stem cell niches.
Ă–zdemir BC; Hensel J; Secondini C; Wetterwald A; Schwaninger R; Fleischmann A; Raffelsberger W; Poch O; Delorenzi M; Temanni R; Mills IG; van der Pluijm G; Thalmann GN; Cecchini MG
PLoS One; 2014; 9(12):e114530. PubMed ID: 25485970
[TBL] [Abstract][Full Text] [Related]
18. The multifaceted role of periostin in priming the tumor microenvironments for tumor progression.
Cui D; Huang Z; Liu Y; Ouyang G
Cell Mol Life Sci; 2017 Dec; 74(23):4287-4291. PubMed ID: 28884337
[TBL] [Abstract][Full Text] [Related]
19. Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G
Lee E; Decker AM; Cackowski FC; Kana LA; Yumoto K; Jung Y; Wang J; Buttitta L; Morgan TM; Taichman RS
J Cell Biochem; 2016 Dec; 117(12):2815-2824. PubMed ID: 27153245
[TBL] [Abstract][Full Text] [Related]
20. Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.
Cackowski FC; Taichman RS
Bone; 2019 Feb; 119():82-86. PubMed ID: 29496517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]